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in conjugation with a 30-lb weight loss. Significant fever,
leukocytosis, microcytic anemia, and elevated liver enzyme
levels accompanied these episodes and eventually became
persistent and unrelenting. The patient underwent cholecys-
tectomy and exploratory laparotomy without resolution. She
had donated a kidney to a sibling 18 years before and subse-
quently had progressive renal insufficiency with a creatinine
level of 2.0 mg/dL that delayed obtaining good contrast-
enhanced abdominal computed tomographic scans. She was
referred for endoscopic ultrasonography to evaluate for possi-
ble chronic pancreatitis. This showed a normal pancreas; how-
ever, a large intra-aortic mass was seen extending from the
mid thoracic aorta to the origin of the superior mesenteric
artery, with no flow in the celiac origin on Doppler examina-
tion. This was confirmed by magnetic resonance imaging and
contrast-enhanced computed tomography, which revealed an
irregular filling defect in the mid thoracic aorta, extending
into the abdominal aorta, occluding the celiac axis, and termi-
nating 2 cm into the proximal superior mesenteric artery (Fig
Primary malignant tumors of the aorta are rare, and prima-
ry sarcomas of the aorta are even more so. This report presents
a unique case of a myxoid leiomyosarcoma successfully
removed from the descending aorta after presentation with
mesenteric ischemia. The majority of aortic malignant tumors
will reach clinical attention because of tumor embolism.
Although cure is unlikely, this case supports an aggressive
multidisciplinary approach to the treatment of these rare slow-
growing tumors for palliation.
A 48-year-old woman presented with a 2-year history of
sharp epigastric pain often radiating to both upper quadrants
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however, she was able to return to work, eat, and gain weight.
She ultimately died of cancer at 18 months from intra-
abdominal and pelvic metastatic disease.
Primary aortic tumors are rare, with only 42 cases reported
in the world literature. It was not until 1960 that the first ante-
mortem diagnosis of an aortic tumor was made in a 22-year-
old woman with malignant hypertension and a thoracoab-
dominal fibromyxoma.1,2
Morphologically, 3 growth patterns of primary aortic sarco-
mas have emerged: intraluminal, intimal, and mural or adventi-
tial. Intraluminal tumors, as in this case, are generally polypoid,
growing in the direction of vascular flow. They present either
with local obstruction to vascular flow or as acute embolic
events.2,3 These tumors are slow growing, as is evidenced in this
case, and usually very difficult to diagnose, presenting only in
very advanced stages or when tumor embolization causes
obstruction of a peripheral artery. Although these tumors do
present in advanced stages, primary resection for palliation fol-
lowed by surveillance and more localized treatment of metasta-
tic lesions provides good symptomatic relief and avoidance of
arterial embolization. In this case cytotoxic chemotherapy was
not given because of the good palliation from surgery and radi-
ation and the lack of any strong data to support chemotherapy
in slow-growing myxoid leiomyosarcomas.
We recommend that aggressive tumor extirpation be the
operation of choice for intraluminal leiomyosarcomas and
not radical aortic resection. The goal of surgery is not cure
but palliation. Local recurrence was not seen, and the tumor
was easily removed. Subsequent aggressive radiation and fix-
ation of other metastatic lesions are also warranted by the
potential of long survival. Extra-anatomic bypass could be
performed, but the ease of removal and decreased risk of
large embolization favor tumor endarterectomy over bypass.
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1). A single right kidney demonstrated multiple wedge-
shaped areas of hypodensity consistent with infarction or
embolization, and leg x-ray films revealed multiple lytic
lesions in the long bones.
Although she obviously had widely metastatic lesions, we
elected to attempt tumor removal for palliation because the
symptoms of mesenteric ischemia were severe. Through an
extensive thoracoabdominal incision with medial visceral
rotation and division of the diaphragm, the descending aorta
and mesenteric arterial origins were exposed. Spinal cord
protection was planned with a lumbar drain, and left heart
bypass was placed on standby if the resection became exten-
sive. There was no evidence of extraluminal tumor. With the
use of intraoperative ultrasonography, the proximal tumor
margins were identified, and the aorta was appropriately
crossclamped. When the aorta was entered longitudinally, a
large amount of gelatinous tumor extruded from the incision
(Fig 2). The material was adherent to the intima by delicate
fibrous strands and was easily removed with simple
endarterectomy techniques. The celiac axis was opened with
tumor thrombectomy, and all visible gross tumor was
removed. The superior mesenteric artery was only partially
obstructed by tumor and was also easily opened with ever-
sion embolectomy. The aorta was closed with a patch to
widen the lumen in case of future tumor recurrence.
Crossclamp time was 31 minutes. Postoperatively, there was
no evidence of embolic phenomena in the extremities, and
the patient was neurologically intact.
The patient was discharged from the hospital on postoper-
ative day 12 with complete resolution of her abdominal pain.
Additionally, she was no longer febrile, and her creatinine
level, liver enzyme levels, amylase level, lipase level, and
white counts were within normal limits.
Subsequent follow-up revealed more metastatic bone
lesions in her legs for which she received palliative radiation
therapy and internal fixation of the fibula. At 12 months’ fol-
low-up, she remained asymptomatic from the primary tumor,
and repeat magnetic resonance imaging showed no recurrent
aortic mass. She continued to experience significant lower
extremity bone pain from slow-growing metastatic lesions;
Fig 2. Pathology specimen removed from the aorta. This was
the main portion removed from the mid descending thoracic
aorta. It was loosely attached posteriorly and was easily
removed by peeling the tumor mass away from the intima.
Fig 1. Magnetic resonance image and contrast-enhanced
computed tomography scan of the aorta showing the intralu-
minal tumor beginning at the mid descending thoracic aorta
and extending down to the level of the mesenteric vessels
almost completely occluding the lumen.
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